EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Altered gut microbiome, bile acid composition and metabolome in sarcopenia in liver cirrhosis

Benard Aliwa iD, Angela Horvath, Julia Traub, Nicole Feldbacher, Hansjörg Habisch, Günter Fauler, Tobias Madl, Vanessa Stadlbauer iD

Journal of Cachexia, Sarcopenia and Muscle · 2023-12 · 14 (6) · 2676-2691

DOI: 10.1002/jcsm.13342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 28.09.2023. Verfasst von Benard Aliwa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Sarcopenia. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund, Austrian Research Promotion Agency, Integrative Metabolism Research Center Graz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sarcopenia in liver cirrhosis is associated with low quality of life and high mortality risk. The pathogenesis has yet to be fully understood. We hypothesized that gut microbiome, bile acid (BA) composition and metabolites differ between cirrhotic patients with and without sarcopenia and contribute to pathogenesis.

Methods

Cirrhotic patients with ( n = 78) and without ( n = 38) sarcopenia and non‐cirrhotic controls with ( n = 39) and without ( n = 20) sarcopenia were included in this study. Faecal microbiome composition was studied by 16S rDNA sequencing, serum and faecal BA composition by ultra‐high‐performance liquid chromatography–tandem mass spectrometry, and metabolite composition in serum, faeces and urine by nuclear magnetic resonance.

Results

Bacteroides fragilis , Blautia marseille , Sutterella spp. and Veillonella parvula were associated with cirrhotic patients with sarcopenia, whereas Bacteroides ovatus was more abundant in cirrhotic patients without sarcopenia. We observed significantly elevated secondary BAs, deoxycholic acid (DCA; P = 0.01) and lithocholic acid (LCA; P = 0.02), and the ratios of deoxycholic acid to cholic acid (DCA:CA; P = 0.04), lithocholic acid to chenodeoxycholic acid (LCA:CDCA; P = 0.03) and 12 alpha‐hydroxylated to non‐12 alpha‐hydroxylated BAs (12‐α‐OH:non‐12‐α‐OH BAs; P = 0.04) in serum of cirrhotic patients with sarcopenia compared with cirrhotic patients without sarcopenia, indicating an enhanced transformation of primary to secondary BAs by the gut microbiome. CA ( P = 0.02) and the ratios of CA:CDCA ( P = 0.03) and total ursodeoxycholic acid to total secondary BAs (T‐UDCA:total‐sec‐BAs, P = 0.03) were significantly reduced in the stool of cirrhotic patients with sarcopenia compared with cirrhotic patients without sarcopenia. Also, valine and acetate were significantly reduced in the serum of cirrhotic patients with sarcopenia compared with cirrhotic patients without sarcopenia ( P = 0.01 and P = 0.03, respectively). Multivariate logistic regression further confirmed the association of B. ovatus ( P = 0.01, odds ratio [OR]: 12.8, 95% confidence interval [CI]: 168.1; 2.2), the ratios of 12‐α‐OH:non‐12‐α‐OH BAs ( P = 0.03, OR: 2.54, 95% CI: 0.99; 6.55) and T‐UDCA:total‐sec‐BAs ( P = 0.04, OR: 0.25, 95% CI: 0.06; 0.98) in serum and stool CA:CDCA ( P = 0.04, OR: 0.79, 95% CI: 0.62; 0.99), and serum valine ( P = 0.04, OR: 1.00, 95% CI: 1.02; 1.00) with sarcopenia in cirrhosis after correcting for the severity of liver disease and sex.

Conclusions

Our study suggests a potential functional gut microbiome–host interaction linking sarcopenia with the altered gut microbiomes, BA profiles and amino acids pointing towards a potential mechanistic interplay in understanding sarcopenia pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeSarcopeniaHumansBile Acids and SaltsQuality of LifeLiver CirrhosisLithocholic AcidMetabolomeDeoxycholic AcidValine

Stichwörter der Autor:innen

bile acidscirrhosisgut microbiomemetabolomesarcopenia

Substanzen

Bile Acids and SaltsLithocholic AcidDeoxycholic AcidValine

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Department of Food Science, Nutrition and Technology, University of Nairobi, Nairobi, Kenya.
  • Centre for Biomarker Research in Medicine (CBmed), Graz, Austria.
  • Department of Clinical Medical Nutrition, University Hospital Graz, Graz, Austria.
  • Gottfried Schatz Research Center, Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.
  • Clinical Institute for Medical and Chemical Laboratory Diagnostics, Graz, Austria.

ORCID-Profile: Benard Aliwa, Vanessa Stadlbauer

Förderung

  • Austrian Science Fund
  • Austrian Research Promotion Agency
  • Integrative Metabolism Research Center Graz
  • Austrian Science Fund FWF
  • Styrian Government
  • BioTechMed-Graz
  • City of Graz
  • Austrian Infrastructure Program 2016/2017

Zitieren

APA

Aliwa, B., Horvath, A., Traub, J., Feldbacher, N., Habisch, H., Fauler, G., Madl, T., & Stadlbauer, V. (2023). Altered gut microbiome, bile acid composition and metabolome in sarcopenia in liver cirrhosis. Journal of Cachexia, Sarcopenia and Muscle, 14(6), 2676-2691. https://doi.org/10.1002/jcsm.13342

Vancouver

Aliwa B, Horvath A, Traub J, Feldbacher N, Habisch H, Fauler G, et al. Altered gut microbiome, bile acid composition and metabolome in sarcopenia in liver cirrhosis. Journal of Cachexia, Sarcopenia and Muscle. 2023;14(6):2676-2691. doi:10.1002/jcsm.13342

BibTeX
@article{Aliwa2023,
  author = {Aliwa, Benard and Horvath, Angela and Traub, Julia and Feldbacher, Nicole and Habisch, Hansjörg and Fauler, Günter and Madl, Tobias and Stadlbauer, Vanessa},
  title = {Altered gut microbiome, bile acid composition and metabolome in sarcopenia in liver cirrhosis},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2023},
  volume = {14},
  number = {6},
  pages = {2676--2691},
  doi = {10.1002/jcsm.13342}
}
Kostenlos starten →